RIO DE JANEIRO, BRAZIL - A combination of the antivirals interferon beta-1b, lopinavir-ritonavir (a medicine used against the HIV virus), and ribavirin (often used in hepatitis C cases) may be a promising treatment against the novel coronavirus.
This is the result of research conducted by six hospitals in Hong Kong and published in the renowned scientific journal The Lancet. The study considered only mild and moderate cases of the virus.
To conduct the study, 127 patients, with an average age of 52 years, were divided into two groups. The first group, with 86 people, was administered the complete cocktail . . .